Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SEN. PRYOR MOVES CLOSER TO PhRMA ON PROPOSED AMENDMENT TO FINANCE COMMITTEE FOR MEDICARE DRUG BENEFIT: LEGISLATIVE PROPOSALS LESS ONEROUS THAN RHETORIC

Executive Summary

Sen. Pryor (D-Ark.) and the Pharmaceutical Research & Manufacturers of America appear to be coming closer on a Medicare outpatient drag benefit. While neither side has dropped the rhetoric of the past six years, two amendments drafted by Pryor for the Senate Finance Committee discussion are remarkably close, in their basic outlines, to the two most prevalent industry approaches to recent Capitol Hill health care reform markups.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS024717

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel